ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA

Clinical trials for ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA trials appear

Sign up with your email to follow new studies for ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo battles Tough-to-Treat skin cancer in major trial

Disease control Ongoing

This study is testing whether a new combination of two drugs, naporafenib and trametinib, works better than current standard treatments for people with advanced NRAS-mutant melanoma that has continued to grow after immunotherapy. The trial will compare how long patients live with…

Matched conditions: ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA

Phase: PHASE3 • Sponsor: Erasca, Inc. • Aim: Disease control

Last updated Mar 09, 2026 14:24 UTC

ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA

Get alerted when new ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA trials appear

New drug duo battles Tough-to-Treat skin cancer in major trial